XPOF earnings analysis
What we found in XPOF's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Q2 2026 revenue of $65.968 million improved 8.1% sequentially and exceeded consensus by 2.2%, but remained 13.2% below Q2 2025 and diluted EPS of $0.02 missed the $0.13 estimate by $0.11. The filing provides no new quantitative guidance in the supplied MD&A excerpt. Key concerns are $522.4 million of variable-rate debt, $5.2 million of annual interest-expense sensitivity to a 1% rate change, persistent ineffective disclosure controls as of June 30, 2026, and the ongoing strategic-alternatives review.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Rebounded Sequentially
- Q2 2026 revenue was $65.968 million, up approximately 8.1% from $61 million in Q1 2026 but down approximately 13.2% from $76 million in Q2 2025. Revenue exceeded the $64.546 million consensus estimate by approximately 2.2%.
- EPS Missed Consensus
- Reported diluted EPS was $0.02 versus the $0.13 consensus estimate, a shortfall of $0.11 per share and an approximately 84.6% negative surprise.
- Variable-Rate Debt Remains High
- The company reported that $522.4 million of outstanding Credit Agreement principal, net of exit fee, was subject to variable interest rates as of June 30, 2026.
- Rate Sensitivity Quantified
- Management stated that a hypothetical 1% change in interest rates would change annual interest expense by approximately $5.2 million based on the June 30, 2026 debt balance.
- Remediation Progress Continues
- Management reported progress on remediation, but its evaluation remained ongoing as of June 30, 2026; disclosure controls and procedures were still not effective because of material weaknesses identified in the 2025 Form 10-K.
- Strategic Review Remains Active
- The Board's strategic-alternatives review, first disclosed in the April 7, 2026 Form 8-K, remains ongoing and may include a sale, merger, or other strategic or financial transaction.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Strategic Review May Not Conclude
- The company states that its strategic-alternatives review, disclosed on April 7, 2026, may not result in a transaction or may not produce favorable terms. Management warned the process could divert attention from operations and increase volatility in the Class A common stock.
- Material Control Weakness Persists
- As of June 30, 2026, disclosure controls and procedures were not effective due to material weaknesses from the 2025 Form 10-K. The cited weakness includes insufficient accounting, financial reporting, and technology personnel and deficiencies in IT general controls.
- Interest-Rate and Debt Exposure
- The filing identifies variable-rate debt of $522.4 million and estimates that a 1% increase in interest rates would raise annual interest expense by approximately $5.2 million. Higher rates or additional indebtedness could further pressure earnings and liquidity.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.02
What they said about what is next.
The provided 10-Q excerpt does not include quantitative revenue or EPS guidance. Prior analysis cited full-year 2026 revenue guidance of $260 million-$270 million, but this filing excerpt does not state whether that outlook was maintained, raised, lowered, or withdrawn.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 8, 2026
- Xponential Fitness, Inc. reported disappointing Q1 2026 results, with revenue declining to $60.7 million, missing expectations of $63.9 million, and an EPS of -$0.04, falling short of the estimated $0.12. The company…
- 10-K · March 4, 2026
- Xponential’s 2025 10-K positions the company as a scaled, multi-brand franchisor with 2,606 open studios in North America, five core brands and ~78% of 2025 revenue described as recurring. Operational traction (59.2…
- 10-Q · August 8, 2025
- Xponential reported Q2 net revenue of $76,208,000, essentially flat year-over-year (down $695,000 vs $76,903,000). Gross margin expanded to 81.0% and operating income turned positive to $14,823,000 (19.5% operating…
- 10-Q · May 9, 2025
- Xponential reported Q1 revenue of $76,883,000, down $2,810,000 (3.5%) versus Q1 2024, while operating income improved to $9,679,000 (operating margin ~12.6%) from $7,994,000 a year ago. GAAP net loss was $2,659,000 (net…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing XPOF makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever